sulfaphenazole has been researched along with Ataxia in 1 studies
Sulfaphenazole: A sulfonilamide anti-infective agent.
sulfaphenazole : A sulfonamide that is sulfanilamide in which the sulfonamide nitrogen is substituted by a 1-phenyl-1H-pyrazol-5-yl group. It is a selective inhibitor of cytochrome P450 (CYP) 2C9 isozyme, and antibacterial agent.
Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ENGE, S | 1 |
| LECHNER, H | 1 |
| FALK, W | 1 |
1 other study available for sulfaphenazole and Ataxia
| Article | Year |
|---|---|
[ELECTROENCEPHALOGRAMS IN CHILDREN FOLLOWING ORAL ADMINISTRATION OF 3-(P-AMINO-BENZOL-SULFONAMIDO)-2-PHENYLPYRAZOLE(ORISUL)].
Topics: Administration, Oral; Ataxia; Benzene; Child; Electroencephalography; Epilepsy; Epilepsy, Absence; H | 1963 |